BNP Paribas Financial Markets
PALI icon

BNP Paribas Financial Markets’s Palisade Bio PALI Stock Holding History

BNP Paribas Financial Markets’s Portfolio PALI Stock Details PALI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$47.1K Sell
22,550
-166,711
-88% -$328K ﹤0.01% 4911
2026
Q1 		$331K Buy
+189,261
New +$344K ﹤0.01% 3807
2015
Q2 		– Hold
0
– -$3.15K – 3598
2015
Q1 		– Hold
0
– – – 3369
2014
Q4 		– Hold
0
– -$13.6K – 2845
2014
Q3 		– Hold
0
– – – 3416

Other funds holding PALI

SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BGI
B Group Inc Dallas, Texas $213M AUM 96.05% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

BNP Paribas Financial Markets's PALI Position: Q2 2026 in Review

BNP Paribas Financial Markets reduced its Palisade Bio (PALI) stake by 88% in Q2 2026, selling an estimated $328K and leaving 22,550 shares worth $47.1K. The position accounts for ﹤0.01% of the portfolio, ranked #4911.

BNP Paribas Financial Markets first reported a position in PALI in Q1 2026 and has held it in 2 quarters since. The position peaked at $331K in Q1 2026. 124 funds tracked by Wall St. Rank hold PALI as of Q2 2026.

  • BNP Paribas Financial Markets held 22,550 shares of Palisade Bio worth $47.1K as of Q2 2026.
  • BNP Paribas Financial Markets sold 166,711 Palisade Bio shares in Q2 2026, an estimated $328K.
  • Palisade Bio made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #4911 holding.
  • BNP Paribas Financial Markets first reported a position in Palisade Bio in Q1 2026 and has held it in 2 quarters since.
  • BNP Paribas Financial Markets's Palisade Bio position peaked at $331K in Q1 2026.
  • 124 funds tracked by Wall St. Rank held Palisade Bio as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.